Skip to main content

Critical Illness clinical trials at UC Health

3 in progress, 2 open to eligible people

Showing trials for
  • Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment

    open to eligible people ages 18 years and up

    This study evaluates a novel arm restraint compared with traditional soft wrist restraints in older critically ill patients. The primary outcome is upper extremity mobility measured by actigraphy, and secondary outcomes include sedation, agitation, satisfaction, and acceptability.

    at UCSD

  • Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19

    open to eligible people ages 18 years and up

    The novel coronavirus (COVID-19) is affecting the way many people live their lives, including seeking medical care and maintaining good self-care to keep healthy. Additionally, in the event many people become critically ill at once, COVID-19 has the possibility of overwhelming hospitals to the point where they have to make decisions about how to determine who receives intensive care and life-support measures. Many hospitals as well as local or state governments have been working on policies to determine how to make these decisions. This study seeks to learn about how COVID-19 has affected the way patients and healthcare providers care for themselves and about their thoughts and concerns about policies that may "ration" life-support resources.

    at UCLA

  • Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery

    Sorry, currently not accepting new patients, but might later

    Prospective multi-center phase 2b randomized placebo-controlled double-blinded interventional platform trial of two different pharmacologic therapies (intravenous Vitamin C or intravenous Acetaminophen) for patients with sepsis-induced hypotension or respiratory failure.

    at UC Davis UCLA UCSF

Last updated: